Bin Zhao - Concepedia

Author

Bin Zhao

Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University ORCID

Also Known As

B. Zhao, BIN ZHAO, Bin N. Zhao, Bin Zhao, Bingjing Zhao, Juling Ji, Zhao B

110

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University Merck & Co., Inc., Rahway, NJ, USA (United States)Wenzhou Medical University Third Affiliated Hospital of Harbin Medical University Harbin Medical University

About

Bin Zhao is an author at Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	340
2	Health Sciences	2	2	84
3	Engineering	1	1	44
4	Social Sciences	1	1	15
5	Biomedical Engineering	1	1	44

Bin Zhao

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50% Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Journal of Clinical Oncology	2021	1K
Macropinocytosis Is the Endocytic Pathway That Mediates Macrophage Foam Cell Formation with Native Low Density Lipoprotein Howard S. Kruth, Nancy Lee Jones, Wei Huang, Journal of Biological Chemistry	2004	272
Efficacy of PD-1/PD-L1 blockade monotherapy in clinical trials Bin Zhao, Hong Zhao, Jiaxin Zhao Therapeutic Advances in Medical Oncology	2020	212
Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407 Steven Powell, Delvys Rodríguez‐Abreu, Corey J. Langer, Journal of Thoracic Oncology	2021	176
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC Mark M. Awad, Shirish M. Gadgeel, Hossein Borghaei, Journal of Thoracic Oncology Advanced Nonsquamous NsclcMedicineWithout PembrolizumabImmune Checkpoint InhibitorPharmacotherapy	2020	175
Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy Mingdong Lu, Bin Zhao, Mengshan Liu, npj Precision Oncology	2021	124
Redistribution of macrophage cholesteryl ester hydrolase from cytoplasm to lipid droplets upon lipid loading Bin Zhao, Bernard Fisher, Richard W. St. Clair, Journal of Lipid Research	2005	57
Effects of poly(l-lysine)-modified Fe3O4 nanoparticles on endogenous reactive oxygen species in cancer stem cells Xueqin Wang, Qin Tu, Bin Zhao, Biomaterials NanoparticlesEngineeringNanobiotechnologyNano-drug DeliveryTumor Targeting	2012	44
Autophagy-based survival prognosis in human colorectal carcinoma Maopeng Yang, Hong Zhao, Li Guo, Oncotarget	2015	44
Risk factors and outcomes of hospitalized patients with blood infections caused by multidrug-resistant Acinetobacter baumannii complex in a hospital of Northern China Ninghui Guo, Wencheng Xue, Dahai Tang, American Journal of Infection Control Health SciencesBlood InfectionsMedicineHealthcare-associated InfectionClinical Epidemiology	2016	40

Page 1